Comparing any AUS med tech company to PME is not wishful thinking. PME has a AUS $27.7 billion market capitalization primarily due to its 330 PE ratio. However, my focus isn't on the ratio. I'm more interested in revenue, and more specifically, profits and market capture growth per annum.
ASX PME Financial Year / Net Profit After Tax (NPAT):
- FY2024: $82.79 million
- FY2023: $66.92 million
- FY2022: $49.62 million
- FY2021: $30.85 million
Pro Medicus Limited (ASX: PME) was founded in 1983 and has been publicly listed since October 2000.- 24 years ago!
Do you think it’s wishful thinking for EIQ to achieve similar profit levels in the next 24 years?
(20min delay)